CVS · CVS HEALTH Corp
$97.16
+2.17 (+2.28%)
At close · Aug 14
Market Cap
$124.26B
Shares
1.28B
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| David Joyner | CEO | $21,214,084 |
| J. David Joyner | President and Chief Executive Officer | $21,214,084 |
| Prem S. Shah | Executive Vice President and Group President | $13,379,210 |
| Prem Shah | — | $13,379,210 |
| Steven H. Nelson | Executive Vice President and President, Aetna | $11,587,110 |
| Tilak Mandadi | Executive Vice President, Ventures and Chief Experience and Technology Officer | $10,977,716 |
| Brian O. Newman | Executive Vice President and Chief Financial Officer | $9,420,508 |
| Thomas F. Cowhey | Former Executive Vice President and Chief Financial Officer | $6,715,138 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Karen Lynch | Former President and Chief Executive Officer | $23,431,466 |
| J. David Joyner | President and Chief Executive Officer | $17,808,792 |
| David Joyner | CEO | $17,808,792 |
| Prem S. Shah | Executive Vice President and Group President | $13,265,855 |
| Prem Shah | — | $13,265,855 |
| Tilak Mandadi | Executive Vice President Ventures, and Chief Digital, Data, Analytics and Technology Officer | $11,361,343 |
| Thomas F. Cowhey | Former Executive Vice President and Chief Financial Officer | $7,644,364 |
| Heidi B. Capozzi | Executive Vice President and Chief People Officer | $6,850,748 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Karen Lynch | Former President and Chief Executive Officer | $21,615,034 |
| Shawn Guertin | Former Executive Vice President, Chief Financial Officer and President of Health Services | $12,494,134 |
| Samrat S. Khichi | Executive Vice President, Chief Policy Officer and General Counsel | $11,886,503 |
| Tilak Mandadi | Executive Vice President Ventures, and Chief Digital, Data, Analytics and Technology Officer | $8,881,845 |
| Prem S. Shah | Executive Vice President and Group President | $8,582,366 |
| Prem Shah | — | $8,582,366 |
| Thomas F. Cowhey | Senior Vice President and Interim Chief Financial Officer | $4,579,937 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Karen Lynch | Former President and Chief Executive Officer | $21,317,055 |
| Shawn Guertin | Former Executive Vice President, Chief Financial Officer and President of Health Services | $14,630,713 |
| Tilak Mandadi | Executive Vice President Ventures, and Chief Digital, Data, Analytics and Technology Officer | $13,991,858 |
| Alan Lotvin | Former Executive Vice President and President – Pharmacy Services | $10,983,750 |
| Prem Shah | — | $9,015,218 |
| Prem S. Shah | Executive Vice President and Group President | $9,015,218 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Karen Lynch | President and Chief Executive Officer | $20,388,412 |
| Jonathan C. Roberts | Executive Vice President and Chief Operating Officer | $15,354,581 |
| Shawn Guertin | Former Executive Vice President, Chief Financial Officer and President of Health Services | $14,339,230 |
| Alan Lotvin | Former Executive Vice President and President – Pharmacy Services | $11,011,560 |
| Eva Boratto | Former Executive Vice President and Chief Financial Officer | $9,885,690 |
| Troyen A. Brennan | Executive Vice President and Chief Medical Officer | $8,793,264 |
| Larry Merlo | Former President and Chief Executive Officer | $3,784,072 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Larry Merlo | Former President and Chief Executive Officer | $23,043,822 |
| Jonathan C. Roberts | Executive Vice President and Chief Operating Officer | $13,001,212 |
| Karen Lynch | President and Chief Executive Officer | $11,307,916 |
| Eva Boratto | Former Executive Vice President and Chief Financial Officer | $8,921,153 |
| Alan Lotvin | Former Executive Vice President and President – Pharmacy Services | $7,472,175 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Larry Merlo | Former President and Chief Executive Officer | $36,451,749 |
| Thomas M. Moriarty | Executive Vice President, Chief Policy and External Affairs Officer and General Counsel | $23,154,934 |
| Jonathan C. Roberts | Executive Vice President and Chief Operating Officer | $15,048,380 |
| Derica W. Rice | Executive Vice President and President – CVS Caremark | $10,626,219 |
| Eva Boratto | Former Executive Vice President and Chief Financial Officer | $9,564,223 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Larry Merlo | President and Chief Executive Officer | $21,939,098 |
| Jonathan C. Roberts | Executive Vice President and Chief Operating Officer | $16,066,968 |
| Thomas M. Moriarty | Executive Vice President, Chief Policy and External Affairs Officer and General Counsel | $10,983,856 |
| Eva Boratto | Executive Vice President and Chief Financial Officer | $6,972,421 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Larry Merlo | President and Chief Executive Officer | $12,252,864 |
| Jonathan C. Roberts | Executive Vice President and Chief Operating Officer | $6,882,764 |
| Thomas M. Moriarty | Executive Vice President, Chief Policy and External Affairs Officer and General Counsel | $4,512,554 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John E. Gallina | Director | Appointed | 2026-03-19 |
| Amy L. Compton-Phillips | Executive Vice President and Chief Medical Officer | Appointed | 2025-04-08 |
| Brian O. Newman | Executive Vice President and Chief Financial Officer | Appointed | 2025-04-08 |
| Doug Shulman | Board of Directors | Appointed | 2024-11-18 |
| Guy Sansone | Board of Directors | Appointed | 2024-11-18 |
| Larry Robbins | Board of Directors | Appointed | 2024-11-18 |
| Leslie Norwalk | Board of Directors | Appointed | 2024-11-18 |
| Steven H. Nelson | Executive Vice President and President of Aetna | Appointed | 2024-11-06 |
| Prem S. Shah | Executive Vice President and Group President | Appointed | 2024-11-06 |
| Roger N. Farah | Executive Chairman of the Board | Appointed | 2024-10-18 |
| Karen S. Lynch | member of the Board | Resigned | 2024-10-18 |
| Karen S. Lynch | President and Chief Executive Officer | Resigned | 2024-10-18 |
| J. David Joyner | member of the Board | Appointed | 2024-10-18 |
| J. David Joyner | President and Chief Executive Officer | Appointed | 2024-10-18 |
| Thomas F. Cowhey | Executive Vice President and Chief Financial Officer | Appointed | 2024-01-05 |
| Thomas F. Cowhey | Interim Chief Financial Officer | Appointed | 2023-10-16 |
| Michael F. Mahoney | Board of Directors | Appointed | 2023-09-21 |
| J. Scott Kirby | Board | Appointed | 2023-07-20 |
| J. David Joyner | President, Pharmacy Services | Appointed | 2023-01-23 |
| Jeffrey R. Balser, M.D., Ph.D. | Board of Directors | Appointed | 2022-09-13 |
Key facts
CIK
64803
CUSIP
126650100
13F (30d)
1803 filings
1737 filers
Visit website
Investor relations